Trifecta Multimedical's Online Investigator Training Website
Trifecta Multimedical, a global provider of online clinical investigator training, introduced InvestigatorSpace.com, designed to give clinical trial sponsors and sites unprecedented capabilities for clinical training and site operations.
InvestigatorSpace.com streamlines clinical trial site management and oversight without compromising quality or compliance. It is a web-based application that tracks, validates and reports investigator training activity through one simple interface, regardless of how training is conducted.
“We set out to empower investigators in entirely new ways. At the same time, we wanted to provide sponsors with a level of tracking and validation that has simply never been available before,” says Trifecta Multimedical CEO Dave Young.
InvestigatorSpace.com unifies training and collaboration done on-line, at in-person investigator meetings, web conferences and using off-the-shelf solutions provided by competitors.
“InvestigatorSpace.com lets investigators make their own decisions in a controlled manner, taking a huge administrative burden off study teams,” says Young. “It dovetails perfectly with sponsors’ training plans. It’s like the difference between driving a stick shift and an automatic. There are so many steps that are now completely automated.”
InvestigatorSpace.com has been in development for the past two years. During that time, Trifecta continually interviewed sites, sponsors and clinical research organizations regarding training challenges and opportunities to improve site operations. “We wanted to find all the gaps and close them,” says Young. The company expects InvestigatorSpace.com to elevate sponsors’ expectations of training technologies. Young calls it “raising the industry IQ.”
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Improving Engagement While Maintaining Data Integrity & Validity
March 19th 2024In recognition of Women's Health Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and uMotif's Chief Product Officer, Julia Lakeland, discuss new technologies improving patient engagement and reducing the emotional and logistical burdens of participation, ethical considerations that should be addressed when implementing those technologies, while ensuring patient privacy, and much more.
FDA Grants Ziftomenib with Breakthrough Therapy Designation for NPM1-Mutant Acute Myeloid Leukemia
April 23rd 2024Data from the Phase Ib portion of the KOMET-001 trial showed that the once-daily oral treatment may provide a substantial improvement over available therapies for relapsed/refractory NPM1-mutant acute myeloid leukemia.
